Clinical Trial

A Research Study Investigating How a New Medicine NNC0113-5840 Works in People With Overweight or Obesity

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this clinical study is to find out if NNC0113-5840 is safe for treating people with excess body weight. There are 2 study treatments in this study, participants will get either NNC0113-5840 (the product being tested) or Placebo (treatment that has no active medicine in it), Which treatment participants get is decided by chance.
Protocol Amendment History 3 changes
notable Primary completion pushed: 2026-11-26 -> 2026-12-26 2026-08-05
minor Completion pushed: 2026-11-26 -> 2026-12-26 2026-08-05
critical Recruitment opened 2026-06-05
Trial Details
NCT Number NCT07566390
Lead Sponsor Novo Nordisk A/S
Conditions Obesity, Overweight
Enrollment 48 participants
Start Date 2026-05-01
Primary Completion 2026-12-26 (estimated)
Study Completion 2026-12-26 (estimated)
Updated on ClinicalTrials.gov 2026-08-04